Gas plasma irradiation of breast cancers promotes immunogenicity, tumor reduction, and an abscopal effect in vivo

References

• Li, N.; Deng, Y.; Zhou, L.; Tian, T.; Yang, S.; Wu, Y.; Zheng, Y.; Zhai, Z.; Hao, Q.; Song, D.; Zhang, D.; Kang, H.; Dai, Z. Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: Results from the global burden of disease study 2017. J Hematol Oncol. 2019;12:140. doi:10.1186/s13045-019-0828-0..
   Google Scholar
• Curado MP. Breast cancer in the world: incidence and mortality. Salud Publica Mex. 2011;53:372–14.
   PubMed Web of Science ®Google Scholar
• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. doi:10.3322/caac.20107.
   PubMed Web of Science ®Google Scholar
• Chakraborty S, Rahman T. The difficulties in cancer treatment. Ecancermedicalscience. 2012;6:ed16. doi:10.3332/ecancer.2012.ed16.
   PubMedGoogle Scholar
• Guan X. Cancer metastases: challenges and opportunities. Acta Pharm Sin B. 2015;5(5):402–418. doi:10.1016/j.apsb.2015.07.005.
   PubMed Web of Science ®Google Scholar
• Coleman RE, Lipton A, Roodman GD, Guise TA, Boyce BF, Brufsky AM, Clezardin P, Croucher PI, Gralow JR, Hadji P, et al. Metastasis and bone loss: advancing treatment and prevention. Cancer Treat Rev. 2010;36:615–620. doi:10.1016/j.ctrv.2010.04.003.
   PubMed Web of Science ®Google Scholar
• Falzone L, Salomone S, Libra M. Evolution of cancer pharmacological treatments at the turn of the third millennium. Front Pharmacol. 2018;9:1300. doi:10.3389/fphar.2018.01300.
   PubMed Web of Science ®Google Scholar
• Mokhtari RB, Homayouni TS, Baluch N, Morgatskaya E, Kumar S, Das B, Yeger H. Combination therapy in combating cancer. Oncotarget. 2017;8(23):38022. doi:10.18632/oncotarget.16723.
   PubMedGoogle Scholar
• Pucci C, Martinelli C, Ciofani G. Innovative approaches for cancer treatment: current perspectives and new challenges. Ecancermedicalscience. 2019;13:961. doi:10.3332/ecancer.2019.961.
   PubMed Web of Science ®Google Scholar
• Vanneman M, Dranoff G. Combining immunotherapy and targeted therapies in cancer treatment. Nat Rev Cancer. 2012;12:237–251. doi:10.1038/nrc3237.
   PubMed Web of Science ®Google Scholar
• Sudhakar A. History of cancer, ancient and modern treatment methods. J Cancer Sci Ther. 2009;1:1–4. doi:10.4172/1948-5956.100000e2.
   PubMedGoogle Scholar
• Tokumaru Y, Joyce D, Takabe K. Current status and limitations of immunotherapy for breast cancer. Surgery. 2020;167(3):628–630. doi:10.1016/j.surg.2019.09.018.
   PubMed Web of Science ®Google Scholar
• Woodward WA. Building momentum for subsets of patients with advanced triple-negative breast cancer. Lancet Oncol. 2020;21(1):3–5. doi:10.1016/S1470-2045(19)30737-5.
   PubMed Web of Science ®Google Scholar
• Schmid P, Rugo HS, Adams S, Schneeweiss A, Barrios CH, Iwata H, Dieras V, Henschel V, Molinero L, Chui SY, et al. Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (impassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2020;21(1):44–59. doi:10.1016/S1470-2045(19)30689-8.
   PubMed Web of Science ®Google Scholar
• Bhandaru M, Rotte A. Monoclonal antibodies for the treatment of melanoma: present and future strategies. Methods Mol Biol. 2019;1904:83–108. doi:10.1007/978-1-4939-8958-4_4.
   PubMedGoogle Scholar
• Berner F, Bomze D, Diem S, Ali OH, Fassler M, Ring S, Niederer R, Ackermann CJ, Baumgaertner P, Pikor N, et al. Association of checkpoint inhibitor-induced toxic effects with shared cancer and tissue antigens in non-small cell lung cancer. JAMA Oncol. 2019;5:1043–1047. doi:10.1001/jamaoncol.2019.0402.
   PubMed Web of Science ®Google Scholar
• Samstein RM, Lee CH, Shoushtari AN, Hellmann MD, Shen R, Janjigian YY, Barron DA, Zehir A, Jordan EJ, Omuro A, et al. Tumor mutational load predicts survival after immunotherapy across multiple cancer types. Nat Genet. 2019;51:202–206. doi:10.1038/s41588-018-0312-8.
   PubMed Web of Science ®Google Scholar
• Schumacher TN, Schreiber RD. Neoantigens in cancer immunotherapy. Science. 2015;348(6230):69–74. doi:10.1126/science.aaa4971.
   PubMed Web of Science ®Google Scholar
• Ruckert M, Deloch L, Fietkau R, Frey B, Hecht M, Gaipl US. Immune modulatory effects of radiotherapy as basis for well-reasoned radioimmunotherapies. Strahlenther Onkol. 2018;194:509–519. doi:10.1007/s00066-018-1287-1.
   PubMed Web of Science ®Google Scholar
• Arina A, Gutiontov SI, Weichselbaum RR. Radiotherapy and immunotherapy for cancer: from “systemic” to “multisite. Clin Cancer Res. 2020. doi:10.1158/1078-0432.CCR-19-2034.
   PubMed Web of Science ®Google Scholar
• Zhang D, Zhou T, He F, Rong Y, Lee SH, Wu S, Zuo L. Reactive oxygen species formation and bystander effects in gradient irradiation on human breast cancer cells. Oncotarget. 2016;7:41622–41636. doi:10.18632/oncotarget.9517.
   PubMedGoogle Scholar
• Pasqual-Melo G, Sagwal SK, Freund E, Gandhirajan RK, Frey B, von Woedtke T, Gaipl U, Bekeschus S. Combination of gas plasma and radiotherapy has immunostimulatory potential and additive toxicity in murine melanoma cells in vitro. Int J Mol Sci. 2020;21:1379. doi:10.3390/ijms21041379.
   PubMed Web of Science ®Google Scholar
• Perillo B, Di Donato M, Pezone A, Di Zazzo E, Giovannelli P, Galasso G, Castoria G, Migliaccio A. Ros in cancer therapy: the bright side of the moon. Exp Mol Med. 2020;52:192–203. doi:10.1038/s12276-020-0384-2.
   PubMed Web of Science ®Google Scholar
• Dai X, Bazaka K, Richard DJ, Thompson ERW, Ostrikov KK. The emerging role of gas plasma in oncotherapy. Trends Biotechnol. 2018;36:1183–1198. doi:10.1016/j.tibtech.2018.06.010.
   PubMed Web of Science ®Google Scholar
• Privat-Maldonado A, Schmidt A, Lin A, Weltmann KD, Wende K, Bogaerts A, Bekeschus S. Ros from physical plasmas: redox chemistry for biomedical therapy. Oxid Med Cell Longev. 2019;2019:9062098. doi:10.1155/2019/9062098.
   PubMed Web of Science ®Google Scholar
• Reuter S, von Woedtke T, Weltmann KD. The kinpen-a review on physics and chemistry of the atmospheric pressure plasma jet and its applications. J Phys D: Appl Phys. 2018:51. doi:10.1088/1361-6463/aab3ad.
   Web of Science ®Google Scholar
• Semmler ML, Bekeschus S, Schafer M, Bernhardt T, Fischer T, Witzke K, Seebauer C, Rebl H, Grambow E, Vollmar B, et al. Molecular mechanisms of the efficacy of cold atmospheric pressure plasma (cap) in cancer treatment. Cancers (Basel). 2020;12(2):269. doi:10.3390/cancers12020269.
   PubMed Web of Science ®Google Scholar
• Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Perfettini JL, Castedo M, Mignot G, Panaretakis T, Casares N, et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med. 2007;13:54–61. doi:10.1038/nm1523.
   PubMed Web of Science ®Google Scholar
• Garg AD, Agostinis P. Cell death and immunity in cancer: from danger signals to mimicry of pathogen defense responses. Immunol Rev. 2017;280:126–148. doi:10.1111/imr.12574.
   PubMed Web of Science ®Google Scholar
• Hasse S, Meder T, Freund E, von Woedtke T, Bekeschus S. Plasma treatment limits human melanoma spheroid growth and metastasis independent of the ambient gas composition. Cancers (Basel). 2020;12(9):2570. doi:10.3390/cancers12092570.
   PubMed Web of Science ®Google Scholar
• Bekeschus S, Clemen R, Niessner F, Sagwal SK, Freund E, Schmidt A. Medical gas plasma jet technology targets murine melanoma in an immunogenic fashion. Adv Sci (Weinh). 2020;7:1903438. doi:10.1002/advs.201903438.
   PubMedGoogle Scholar
• Fucikova J, Moserova I, Truxova I, Hermanova I, Vancurova I, Partlova S, Fialova A, Sojka L, Cartron PF, Houska M, et al. High hydrostatic pressure induces immunogenic cell death in human tumor cells. Int J Cancer. 2014;135:1165–1177. doi:10.1002/ijc.28766.
   PubMed Web of Science ®Google Scholar
• Fucikova J, Kralikova P, Fialova A, Brtnicky T, Rob L, Bartunkova J, Spisek R. Human tumor cells killed by anthracyclines induce a tumor-specific immune response. Cancer Res. 2011;71(14):4821–4833. doi:10.1158/0008-5472.CAN-11-0950.
   PubMed Web of Science ®Google Scholar
• Cirone M, Di Renzo L, Lotti LV, Conte V, Trivedi P, Santarelli R, Gonnella R, Frati L, Faggioni A. Primary effusion lymphoma cell death induced by bortezomib and ag 490 activates dendritic cells through cd91. PLoS One. 2012;7:e31732. doi:10.1371/journal.pone.0031732.
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Buque A, Kepp O, Zitvogel L, Kroemer G. Immunogenic cell death in cancer and infectious disease. Nat Rev Immunol. 2017;17:97–111. doi:10.1038/nri.2016.107.
   PubMed Web of Science ®Google Scholar
• Ledford H, Else H, Warren M. Cancer immunologists scoop medicine nobel prize. Nature. 2018;562(7725):20–21. doi:10.1038/d41586-018-06751-0.
   PubMed Web of Science ®Google Scholar
• Mole RH. Whole body irradiation; radiobiology or medicine? Br J Radiol. 1953;26:234–241. doi:10.1259/0007-1285-26-305-234.
   PubMed Web of Science ®Google Scholar
• Ehlers G, Fridman M. Abscopal effect of radiation in papillary adenocarcinoma. Br J Radiol. 1973;46:220–222. doi:10.1259/0007-1285-46-543-220.
   PubMed Web of Science ®Google Scholar
• Topalian SL, Taube JM, Pardoll DM. Neoadjuvant checkpoint blockade for cancer immunotherapy. Science. 2020:367. doi:10.1126/science.aax0182.
   PubMed Web of Science ®Google Scholar
• Frey B, Rubner Y, Wunderlich R, Weiss EM, Pockley AG, Fietkau R, Gaipl US. Induction of Abscopal Anti-tumor Immunity and Immunogenic Tumor Cell Death by Ionizing Irradiation - Implications for Cancer Therapies. Curr Med Chem. 1751-1764;2012(19). doi:10.2174/092986712800099811.
   Google Scholar
• Schroter P, Hartmann L, Osen W, Baumann D, Offringa R, Eisel D, Debus J, Eichmuller SB, Rieken S. Radiation-induced alterations in immunogenicity of a murine pancreatic ductal adenocarcinoma cell line. Sci Rep. 2020;10:686. doi:10.1038/s41598-020-57456-2.
   PubMed Web of Science ®Google Scholar
• Park SS, Dong H, Liu X, Harrington SM, Krco CJ, Grams MP, Mansfield AS, Furutani KM, Olivier KR, Kwon ED. Pd-1 restrains radiotherapy-induced abscopal effect. Cancer Immunol Res. 2015;3(6):610–619. doi:10.1158/2326-6066.CIR-14-0138.
   PubMed Web of Science ®Google Scholar
• Shiraishi K, Ishiwata Y, Nakagawa K, Yokochi S, Taruki C, Akuta T, Ohtomo K, Matsushima K, Tamatani T, Kanegasaki S. Enhancement of antitumor radiation efficacy and consistent induction of the abscopal effect in mice by eci301, an active variant of macrophage inflammatory protein-1alpha. Clin Cancer Res. 2008;14(4):1159–1166. doi:10.1158/1078-0432.CCR-07-4485.
   PubMed Web of Science ®Google Scholar
• Yin L, Xue J, Li R, Zhou L, Deng L, Chen L, Zhang Y, Li Y, Zhang X, Xiu W, et al. Effect of low-dose radiotherapy on abscopal responses to hypofractionated radiotherapy and anti-pd1 in mice and nsclc patients. Int J Radiat Oncol Biol Phys. 2020. doi:10.1016/j.ijrobp.2020.05.002.
   Google Scholar
• Hu ZI, McArthur HL, Ho AY. The abscopal effect of radiation therapy: what is it and how can we use it in breast cancer? Curr Breast Cancer Rep. 2017;9:45–51. doi:10.1007/s12609-017-0234-y.
   PubMed Web of Science ®Google Scholar
• Grass GD, Krishna N, Kim S. The immune mechanisms of abscopal effect in radiation therapy. Curr Probl Cancer. 2016;40:10–24. doi:10.1016/j.currproblcancer.2015.10.003.
   PubMed Web of Science ®Google Scholar
• Durgeau A, Virk Y, Corgnac S, Mami-Chouaib F. Recent advances in targeting cd8 t-cell immunity for more effective cancer immunotherapy. Front Immunol. 2018;9:14. doi:10.3389/fimmu.2018.00014.
   PubMed Web of Science ®Google Scholar
• Bekeschus S, Masur K, Kolata J, Wende K, Schmidt A, Bundscherer L, Barton A, Kramer A, Broker B, Weltmann KD. Human mononuclear cell survival and proliferation is modulated by cold atmospheric plasma jet. Plasma Process Polym. 2013;10:706–713. doi:10.1002/ppap.201300008.
   Web of Science ®Google Scholar
• Bekeschus S, von Woedtke T, Kramer A, Weltmann K-D, Masur K. Cold physical plasma treatment alters redox balance in human immune cells. Plasma Med. 2013;3:267–278. doi:10.1615/PlasmaMed.2014011972.
   Google Scholar
• Bekeschus S, Kolata J, Winterbourn C, Kramer A, Turner R, Weltmann KD, Broker B, Masur K. Hydrogen peroxide: A central player in physical plasma-induced oxidative stress in human blood cells. Free Radic Res. 2014;48:542–549. doi:10.3109/10715762.2014.892937.
   PubMed Web of Science ®Google Scholar
• Bekeschus S, Rödder K, Schmidt A, Stope MB, von Woedtke T, Miller V, Fridman A, Weltmann K-D, Masur K, Metelmann H-R, et al. Cold physical plasma selects for specific t helper cell subsets with distinct cells surface markers in a caspase-dependent and nf-κb-independent manner. Plasma Process Polym. 2016;13:1144–1150. doi:10.1002/ppap.201600080.
   Web of Science ®Google Scholar
• Zanetti M. Tapping cd4 t cells for cancer immunotherapy: the choice of personalized genomics. J Immunol. 2015;194:2049–2056. doi:10.4049/jimmunol.1402669.
   PubMed Web of Science ®Google Scholar
• Badoual C, Hans S, Rodriguez J, Peyrard S, Klein C, Agueznay Nel H, Mosseri V, Laccourreye O, Bruneval P, Fridman WH, et al. Prognostic value of tumor-infiltrating cd4+ t-cell subpopulations in head and neck cancers. Clin Cancer Res. 2006;12:465–472. doi:10.1158/1078-0432.CCR-05-1886.
   PubMed Web of Science ®Google Scholar
• de Ruiter EJ, Ooft ML, Devriese LA, Willems SM. The prognostic role of tumor infiltrating t-lymphocytes in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis. Oncoimmunology. 2017;6:e1356148. doi:10.1080/2162402X.2017.1356148.
   PubMed Web of Science ®Google Scholar
• Geng Y, Shao Y, He W, Hu W, Xu Y, Chen J, Wu C, Jiang J. Prognostic role of tumor-infiltrating lymphocytes in lung cancer: A meta-analysis. Cell Physiol Biochem. 2015;37(4):1560–1571. doi:10.1159/000438523.
   PubMed Web of Science ®Google Scholar
• Matsumoto H, Thike AA, Li H, Yeong J, Koo SL, Dent RA, Tan PH, Iqbal J. Increased cd4 and cd8-positive t cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer. Breast Cancer Res Treat. 2016;156:237–247. doi:10.1007/s10549-016-3743-x.
   PubMed Web of Science ®Google Scholar
• Antony PA, Piccirillo CA, Akpinarli A, Finkelstein SE, Speiss PJ, Surman DR, Palmer DC, Chan CC, Klebanoff CA, Overwijk WW, et al. Cd8+ t cell immunity against a tumor/self-antigen is augmented by cd4+ t helper cells and hindered by naturally occurring t regulatory cells. J Immunol. 2005;174:2591–2601. doi:10.4049/jimmunol.174.5.2591.
   PubMed Web of Science ®Google Scholar
• Bos R, Sherman LA. Cd4+ t-cell help in the tumor milieu is required for recruitment and cytolytic function of cd8+ t lymphocytes. Cancer Res. 2010;70:8368–8377. doi:10.1158/0008-5472.CAN-10-1322.
   PubMed Web of Science ®Google Scholar
• Tay RE, Richardson EK, Toh HC. Revisiting the role of cd4(+) t cells in cancer immunotherapy-new insights into old paradigms. Cancer Gene Ther. 2020. doi:10.1038/s41417-020-0183-x.
   PubMed Web of Science ®Google Scholar
• Mucida D, Husain MM, Muroi S, van Wijk F, Shinnakasu R, Naoe Y, Reis BS, Huang Y, Lambolez F, Docherty M, et al. Transcriptional reprogramming of mature cd4(+) helper t cells generates distinct mhc class ii-restricted cytotoxic t lymphocytes. Nat Immunol. 2013;14:281–289. doi:10.1038/ni.2523.
   PubMed Web of Science ®Google Scholar
• Aarntzen EH, De Vries IJ, Lesterhuis WJ, Schuurhuis D, Jacobs JF, Bol K, Schreibelt G, Mus R, De Wilt JH, Haanen JB, et al. Targeting cd4(+) t-helper cells improves the induction of antitumor responses in dendritic cell-based vaccination. Cancer Res. 2013;73:19–29. doi:10.1158/0008-5472.CAN-12-1127.
   PubMed Web of Science ®Google Scholar
• Krysko DV, Garg AD, Kaczmarek A, Krysko O, Agostinis P, Vandenabeele P. Immunogenic cell death and damps in cancer therapy. Nat Rev Cancer. 2012;12:860–875. doi:10.1038/nrc3380.
   PubMed Web of Science ®Google Scholar
• Garg AD, Dudek AM, Agostinis P. Cancer immunogenicity, danger signals, and damps: what, when, and how? BioFactors. 2013;39(4):355–367. doi:10.1002/biof.1125.
   PubMed Web of Science ®Google Scholar
• Schulz D, Stancev I, Sorrentino A, Menevse AN, Beckhove P, Brockhoff G, Hautmann MG, Reichert TE, Bauer RJ, Ettl T. Increased pd-l1 expression in radioresistant hnscc cell lines after irradiation affects cell proliferation due to inactivation of gsk-3beta. Oncotarget. 2019;10:573–583. doi:10.18632/oncotarget.26542.
   PubMedGoogle Scholar
• Wu CT, Chen WC, Chang YH, Lin WY, Chen MF. The role of pd-l1 in the radiation response and clinical outcome for bladder cancer. Sci Rep. 2016;6:19740. doi:10.1038/srep19740.
   PubMed Web of Science ®Google Scholar
• Golden EB, Frances D, Pellicciotta I, Demaria S, Helen Barcellos-Hoff M, Formenti SC. Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death. Oncoimmunology. 2014;3(4):e28518. doi:10.4161/onci.28518.
   PubMed Web of Science ®Google Scholar
• Golden EB, Apetoh L. Radiotherapy and immunogenic cell death. Semin Radiat Oncol. 2015;25:11–17. doi:10.1016/j.semradonc.2014.07.005.
   PubMed Web of Science ®Google Scholar
• Panzarini E, Inguscio V, Dini L. Immunogenic cell death: can it be exploited in photodynamic therapy for cancer? Biomed Res Int. 2013, 2013:482160. doi:10.1155/2013/482160.
   PubMed Web of Science ®Google Scholar
• Tanaka M, Kataoka H, Yano S, Sawada T, Akashi H, Inoue M, Suzuki S, Inagaki Y, Hayashi N, Nishie H, et al. Immunogenic cell death due to a new photodynamic therapy (pdt) with glycoconjugated chlorin (g-chlorin). Oncotarget. 2016;7(30):47242–47251. doi:10.18632/oncotarget.9725.
   PubMedGoogle Scholar
• Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer. 2003;3:380–387. doi:10.1038/nrc1071.
   PubMed Web of Science ®Google Scholar
• Sonveaux P. Ros and radiotherapy: more we care. Oncotarget. 2017;8(22):35482–35483. doi:10.18632/oncotarget.16613.
   PubMedGoogle Scholar
• Chen HHW, Kuo MT. Improving radiotherapy in cancer treatment: promises and challenges. Oncotarget. 2017;8(37):62742–62758. doi:10.18632/oncotarget.18409.
   PubMedGoogle Scholar
• Carta S, Castellani P, Delfino L, Tassi S, Vene R, Rubartelli A. Damps and inflammatory processes: the role of redox in the different outcomes. J Leukoc Biol. 2009;86:549–555. doi:10.1189/jlb.1008598.
   PubMed Web of Science ®Google Scholar
• Castellani P, Balza E, Rubartelli A. Inflammation, damps, tumor development, and progression: A vicious circle orchestrated by redox signaling. Antioxid Redox Signal. 2014;20:1086–1097. doi:10.1089/ars.2012.5164.
   PubMed Web of Science ®Google Scholar
• Li G, Tang D, Lotze MT. Menage a trois in stress: damps, redox and autophagy. Semin Cancer Biol. 2013;23:380–390. doi:10.1016/j.semcancer.2013.08.002.
   PubMed Web of Science ®Google Scholar
• Rubartelli A, Lotze MT. Inside, outside, upside down: damage-associated molecular-pattern molecules (damps) and redox. Trends Immunol. 2007;28(10):429–436. doi:10.1016/j.it.2007.08.004.
   PubMed Web of Science ®Google Scholar
• Bekeschus S, Eisenmann S, Sagwal SK, Bodnar Y, Moritz J, Poschkamp B, Stoffels I, Emmert S, Madesh M, Weltmann KD, et al. Xct (slc7a11) expression confers intrinsic resistance to physical plasma treatment in tumor cells. Redox Biol. 2020;30:101423. doi:10.1016/j.redox.2019.101423.
   PubMed Web of Science ®Google Scholar
• Ninomiya K, Ishijima T, Imamura M, Yamahara T, Enomoto H, Takahashi K, Tanaka Y, Uesugi Y, Shimizu N. Evaluation of extra- and intracellular oh radical generation, cancer cell injury, and apoptosis induced by a non-thermal atmospheric-pressure plasma jet. J Phys D: Appl Phys. 2013;46:425401. doi:10.1088/0022-3727/46/42/425401.
   Web of Science ®Google Scholar
• Bekeschus S, Lippert M, Diepold K, Chiosis G, Seufferlein T, Azoitei N. Physical plasma-triggered ros induces tumor cell death upon cleavage of hsp90 chaperone. Sci Rep. 2019;9:4112. doi:10.1038/s41598-019-38580-0.
   PubMed Web of Science ®Google Scholar
• Mirpour S, Piroozmand S, Soleimani N, Jalali Faharani N, Ghomi H, Fotovat Eskandari H, Sharifi AM, Mirpour S, Eftekhari M, Nikkhah M. Utilizing the micron sized non-thermal atmospheric pressure plasma inside the animal body for the tumor treatment application. Sci Rep. 2016;6:29048. doi:10.1038/srep29048.
   PubMed Web of Science ®Google Scholar
• Lin A, Gorbanev Y, De Backer J, Van Loenhout J, Van Boxem W, Lemiere F, Cos P, Dewilde S, Smits E, Bogaerts A. Non-thermal plasma as a unique delivery system of short-lived reactive oxygen and nitrogen species for immunogenic cell death in melanoma cells. Adv Sci (Weinh). 2019;6:1802062. doi:10.1002/advs.201802062.
   PubMedGoogle Scholar
• Bekeschus S, Rodder K, Fregin B, Otto O, Lippert M, Weltmann KD, Wende K, Schmidt A, Gandhirajan RK. Toxicity and immunogenicity in murine melanoma following exposure to physical plasma-derived oxidants. Oxid Med Cell Longev. 2017;2017:4396467. doi:10.1155/2017/4396467.
   PubMed Web of Science ®Google Scholar
• Lin A, Truong B, Patel S, Kaushik N, Choi EH, Fridman G, Fridman A, Miller V. Nanosecond-pulsed dbd plasma-generated reactive oxygen species trigger immunogenic cell death in a549 lung carcinoma cells through intracellular oxidative stress. Int J Mol Sci. 2017;18:966. doi:10.3390/ijms18050966.
   PubMed Web of Science ®Google Scholar
• Bekeschus S, Mueller A, Miller V, Gaipl U, Weltmann K-D. Physical plasma elicits immunogenic cancer cell death and mitochondrial singlet oxygen. IEEE Transactions on Radiation and Plasma Medical Sciences. 2018;2(2):138–146. doi:10.1109/trpms.2017.2766027.
   Web of Science ®Google Scholar
• Lin AG, Xiang B, Merlino DJ, Baybutt TR, Sahu J, Fridman A, Snook AE, Miller V. Non-thermal plasma induces immunogenic cell death in vivo in murine CT26 colorectal tumors. Oncoimmunology. 2018;7(9):e1484978. doi:10.1080/2162402X.2018.1484978.
   PubMed Web of Science ®Google Scholar
• Azzariti A, Iacobazzi RM, Di Fonte R, Porcelli L, Gristina R, Favia P, Fracassi F, Trizio I, Silvestris N, Guida G, et al. Plasma-activated medium triggers cell death and the presentation of immune activating danger signals in melanoma and pancreatic cancer cells. Sci Rep. 2019;9:4099. doi:10.1038/s41598-019-40637-z.
   PubMed Web of Science ®Google Scholar
• Freund E, Liedtke KR, van der Linde J, Metelmann HR, Heidecke CD, Partecke LI, Bekeschus S. Physical plasma-treated saline promotes an immunogenic phenotype in ct26 colon cancer cells in vitro and in vivo. Sci Rep. 2019;9:634. doi:10.1038/s41598-018-37169-3.
   PubMed Web of Science ®Google Scholar
• Bekeschus S, Schmidt A, Niessner F, Gerling T, Weltmann KD, Wende K. Basic research in plasma medicine - a throughput approach from liquids to cells. J Vis Exp. 2017:e56331. doi:10.3791/56331.
   PubMed Web of Science ®Google Scholar
• Liedtke KR, Freund E, Hackbarth C, Heidecke C-D, Partecke L-I, Bekeschus S. A myeloid and lymphoid infiltrate in murine pancreatic tumors exposed to plasma-treated medium. Clin Plas Med. 2018;11:10–17. doi:10.1016/j.cpme.2018.07.001.
   Web of Science ®Google Scholar
• Mizuno K, Yonetamari K, Shirakawa Y, Akiyama T, Ono R. Anti-tumor immune response induced by nanosecond pulsed streamer discharge in mice. J Phys D: Appl Phys. 2017;50:12LT01. doi:10.1088/1361-6463/aa5dbb.
   Web of Science ®Google Scholar
• Mizuno K, Shirakawa Y, Sakamoto T, Ishizaki H, Nishijima Y, Ono R. Plasma-induced suppression of recurrent and reinoculated melanoma tumors in mice. Ieee Trpms. 2018;2:353–359. doi:10.1109/trpms.2018.2809673.
   Google Scholar
• Tresp H, Hammer MU, Winter J, Weltmann KD, Reuter S. Quantitative detection of plasma-generated radicals in liquids by electron paramagnetic resonance spectroscopy. J Phys D: Appl Phys. 2013;46:435401. doi:10.1088/0022-3727/46/43/435401.
   Web of Science ®Google Scholar
• Bekeschus S, Wende K, Hefny MM, Rodder K, Jablonowski H, Schmidt A, Woedtke TV, Weltmann KD, Benedikt J. Oxygen atoms are critical in rendering thp-1 leukaemia cells susceptible to cold physical plasma-induced apoptosis. Sci Rep. 2017;7:2791. doi:10.1038/s41598-017-03131-y.
   PubMed Web of Science ®Google Scholar
• Jablonowski H, von Woedtke T. Research on plasma medicine-relevant plasma–liquid interaction: what happened in the past five years? Clin Plas Med. 2015;3:42–52. doi:10.1016/j.cpme.2015.11.003.
   Web of Science ®Google Scholar
• Winter J, Sousa JS, Sadeghi N, Schmidt-Bleker A, Reuter S, Puech V. The spatio-temporal distribution of he (23s1) metastable atoms in a mhz-driven helium plasma jet is influenced by the oxygen/nitrogen ratio of the surrounding atmosphere. Plasma Sources Sci T. 2015;24:25015–25025. doi:10.1088/0963-0252/24/2/025015.
   Web of Science ®Google Scholar
• Bekeschus S, Winterbourn CC, Kolata J, Masur K, Hasse S, Broker BM, Parker HA. Neutrophil extracellular trap formation is elicited in response to cold physical plasma. J Leukoc Biol. 2016;100:791–799. doi:10.1189/jlb.3A0415-165RR.
   PubMed Web of Science ®Google Scholar
• Chiang CL, Kandalaft LE, Tanyi J, Hagemann AR, Motz GT, Svoronos N, Montone K, Mantia-Smaldone GM, Smith L, Nisenbaum HL, et al. A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedside. Clin Cancer Res. 2013;19(17):4801–4815. doi:10.1158/1078-0432.CCR-13-1185.
   PubMed Web of Science ®Google Scholar
• Tanyi JL, Bobisse S, Ophir E, Tuyaerts S, Roberti A, Genolet R, Baumgartner P, Stevenson BJ, Iseli C, Dangaj D, et al. Personalized cancer vaccine effectively mobilizes antitumor t cell immunity in ovarian cancer. Sci Transl Med. 2018;10. doi:10.1126/scitranslmed.aao5931.
   PubMed Web of Science ®Google Scholar
• Bekeschus S, Schmidt A, Weltmann K-D, von Woedtke T. The plasma jet kinpen – a powerful tool for wound healing. Clin Plas Med. 2016;4:19–28. doi:10.1016/j.cpme.2016.01.001.
   Web of Science ®Google Scholar
• Wende K, Bekeschus S, Schmidt A, Jatsch L, Hasse S, Weltmann KD, Masur K, von Woedtke T. Risk assessment of a cold argon plasma jet in respect to its mutagenicity. Mutat Res Genet Toxicol Environ Mutagen. 2016;798-799:48–54. doi:10.1016/j.mrgentox.2016.02.003.
   PubMed Web of Science ®Google Scholar
• Bekeschus S, Schmidt A, Kramer A, Metelmann HR, Adler F, von Woedtke T, Niessner F, Weltmann KD, Wende K. High throughput image cytometry micronucleus assay to investigate the presence or absence of mutagenic effects of cold physical plasma. Environ Mol Mutagen. 2018;59:268–277. doi:10.1002/em.22172.
   PubMed Web of Science ®Google Scholar
• Kluge S, Bekeschus S, Bender C, Benkhai H, Sckell A, Below H, Stope MB, Kramer A. Investigating the mutagenicity of a cold argon-plasma jet in an het-mn model. PLoS One. 2016;11:e0160667. doi:10.1371/journal.pone.0160667.
   PubMed Web of Science ®Google Scholar
• Schmidt A, Woedtke TV, Stenzel J, Lindner T, Polei S, Vollmar B, Bekeschus S. One year follow-up risk assessment in skh-1 mice and wounds treated with an argon plasma jet. Int J Mol Sci. 2017:18. doi:10.3390/ijms18040868.
   Web of Science ®Google Scholar
• Metelmann H-R, Vu TT, Do HT, Le TNB, Hoang THA, Phi TTT, Luong TML, Doan VT, Nguyen TTH, Nguyen THM, et al. Scar formation of laser skin lesions after cold atmospheric pressure plasma (cap) treatment: A clinical long term observation. Clin Plas Med. 2013;1:30–35. doi:10.1016/j.cpme.2012.12.001.
   Google Scholar
• Biscop E, Lin A, Boxem WV, Loenhout JV, Backer J, Deben C, Dewilde S, Smits E, Bogaerts AA. Influence of cell type and culture medium on determining cancer selectivity of cold atmospheric plasma treatment. Cancers. 2019;11 Basel. doi:10.3390/cancers11091287.
   PubMed Web of Science ®Google Scholar
• Wang M, Holmes B, Cheng X, Zhu W, Keidar M, Zhang LG. Cold atmospheric plasma for selectively ablating metastatic breast cancer cells. PLoS One. 2013;8:e73741. doi:10.1371/journal.pone.0073741.
   PubMed Web of Science ®Google Scholar
• Van der Paal J, Neyts EC, Verlackt CCW, Bogaerts A. Effect of lipid peroxidation on membrane permeability of cancer and normal cells subjected to oxidative stress. Chem Sci. 2016;7:489–498. doi:10.1039/c5sc02311d.
   PubMed Web of Science ®Google Scholar
• Van Boxem W, Van der Paal J, Gorbanev Y, Vanuytsel S, Smits E, Dewilde S, Bogaerts A. Anti-cancer capacity of plasma-treated pbs: effect of chemical composition on cancer cell cytotoxicity. Sci Rep. 2017;7:16478. doi:10.1038/s41598-017-16758-8.
   PubMed Web of Science ®Google Scholar
• Acharya A, Das I, Chandhok D, Saha T. Redox regulation in cancer: A double-edged sword with therapeutic potential. Oxid Med Cell Longev. 2010;3:23–34. doi:10.4161/oxim.3.1.10095.
   PubMed Web of Science ®Google Scholar
• Saadati F, Mahdikia H, Abbaszadeh HA, Abdollahifar MA, Khoramgah MS, Shokri B. Comparison of direct and indirect cold atmospheric-pressure plasma methods in the b16f10 melanoma cancer cells treatment. Sci Rep. 2018;8:7689. doi:10.1038/s41598-018-25990-9.
   PubMed Web of Science ®Google Scholar
• Zhou D, Shao L, Spitz DR. Reactive oxygen species in normal and tumor stem cells. In Adv. Cancer res., Elsevier:. 2014; Vol. 122. 1–67. https://www.sciencedirect.com/science/article/pii/B9780124201170000013
   Google Scholar
• Xiang L, Xu X, Zhang S, Cai D, Dai X. Cold atmospheric plasma conveys selectivity on triple negative breast cancer cells both in vitro and in vivo. Free Radic Biol Med. 2018;124:205–213. doi:10.1016/j.freeradbiomed.2018.06.001.
   PubMed Web of Science ®Google Scholar